| 2HNZ | A:4-429 | CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 |
| 2OPP | A:4-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
| 2OPQ | A:4-429; B: | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
| 2OPR | A:2-429; B: | CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
| 2OPS | A:2-429; B: | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
| 2RF2 | A:1-429; B: | HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI) |
| 3C6T | A:-1-429; B: | CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14 |
| 3C6U | A:0-429; B: | CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22 |
| 3DLE | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590. |
| 3DLG | A:1-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511. |
| 3DYA | A:1-429; B: | HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1 |
| 3FFI | A:1-429; B: | HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR |
| 3I0R | A:0-429; B: | CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3 |
| 3I0S | A:0-429; B: | CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7 |
| 3KJV | B: | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA |
| 3MEC | A:1-429 | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125 |
| 3MEE | A:1-429 | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278 |
| 3QIP | A:1-429; B: | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE |
| 3T19 | A:0-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05 |
| 3T1A | A:0-429; B: | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05 |
| 4I7F | A:1-429; B: | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE |
| 4NCG | A:1-429; B: | DISCOVERY OF DORAVIRINE, AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES |
)
)